US Stock MarketDetailed Quotes

LIMN Liminatus Pharma

Watchlist
  • 8.040
  • -2.030-20.16%
Close May 2 16:00 ET
  • 6.900
  • -1.140-14.18%
Post 20:01 ET
213.86MMarket Cap-20.62P/E (TTM)

About Liminatus Pharma Company

Iris Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 5, 2020 and is headquartered in George Town, KY.

Company Profile

SymbolLIMN
Company NameLiminatus Pharma
Listing DateMar 5, 2021
Founded2020
CEOMr. Chris Kim, J.D.
MarketNASDAQ
AddressZephyr House,122 Mary Street,3rd Floor
CityGeorge Town
ProvinceGeorge Town
CountryCayman Islands (the)
Zip CodeKY1-1001
Phone971-4-396-6949

Company Executives

  • Name
  • Position
  • Salary
  • Chris Kim, J.D.
  • Chief Executive Officer and Director
  • --
  • Scott Dam
  • Chief Financial Officer
  • --
  • Dr. Byong Chul Yoo, PhD
  • Chief Science Officer
  • --
  • Dr. Beom K. Choi
  • Chief Technology Officer
  • --
  • Nicholas Fernandez
  • Independent Director
  • --
  • Dr. Eun Sook Lee, M.D.,PhD
  • Independent Director
  • --
  • Dr. Sang-jin Daniel Lee, PhD
  • Head of Research and Development
  • --

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.